Botánica, biología, composición química y propiedades farmacológicas de Artemisia annua L / Botanic, biology, chemical composition and pharmacological properties of Artemisia annua L

INTRODUCCIÓN: se presenta una revisión bibliográfica sobre Artemisia annua L., una hierba perteneciente al género Artemisia, la cual incluye alrededor de 400 especies. A. annua ha sido utilizada tradicionalmente como tratamiento herbario contra la malaria en China y en otras partes del mundo.OBJETIVOS: recopilar y actualizar la información publicada sobre A. annua.MÉTODOS: se realizó una amplia búsqueda bibliográfica que permitió identificar y consultar varias decenas de artículos científicos referentes a A. annua, sobre todo de los últimos 20 años, así como varios libros y monografías sobre la planta. En el presente trabajo se analizan los aspectos históricos más importantes relacionados con la planta, descripción botánica, origen y distribución geográfica, requerimientos ambientales, composición química, producción de aceites y sus propiedades farmacológicas...

INTRODUCTION: this is a bibliographic review on Artemisia annua L., a medicinal herb from Artemisia gender, which includes approximately 400 species. A. annua, traditionally is used as an herbal treatment against malaria in China and in other world zones.OBJETIVE: to collect and update the information published on Artemisia annua L. METHODS: authors conducted a wide bibliographic review allowed them to identify and to look for some ten scientific articles on A. annua, mainly of the past 20 years, as well as some books and monographs on this plant. Aim of present paper is to analyze the most important historical features related to this plant, a botanical description, origin and geographical distribution, environmental requirements, chemical composition, oil production and its pharmacological properties...

Improvement in the synthetic process of some derivatives of artemisinine containing fluor

The improvement of synthesis of 10-(trifluoroethoxy)-dihydroartemisinin was described. The improved procedure has some advantages like mild reaction conditions, good yields of products, operational simplicity and the ease of isolation and purification of the products

A new catalyst in the synthesis of fluroalkylether derivatives of artemisinine

Synthetic process fluoroalkylether from artemisinine carried out with 2 TF-DHA and DHA derivatives by etherification reaction with fluoroalkylalcohol in appropriate solvent and catalysis. In research process, author found a catalysis for synthetic reaction of 2 non-flo ethyls of DHA that is sulfuric acid. This catalysis is popular and inexpensive, can replace expensive catalysis in previous experimentations

Study on the solid dispersion system of artemisinine

Enteric solid dispersions of artemisinine were prepared by spray drying using methacrylic acid copolymer (Eudragit L100) as carrier and hydroxypropylmethylcellulose (HPMC), Tween 20, PEG 6000, colloidal silica (aerosil) as additives. Spherical solid dispersion particles were obtained. Both solubility and dissolution rate of artemisinine studied in the medium pH 7.2 from all solid dispersions were markedly improved compared with that from the original or spray dried drug powder. The drug release rate of tablets that were made from the solid dispersion with drug-carrier ratio of 1:2 was nearly unchanged in medium pH 7.2 and was retarded in medium pH 1.5 in comparison with the solid dispersion powder.

Exploration of the effects an artemisinine suspension by subcutaneous injection in white mice infected with Plasmodium berghei

Artemisinine was prepared into a suspension suitable for subcutaneous administration in Plasmodium berghei- infected mice. This formulation (20mg/kg b.i.d, total dosage of 200mg/kg) was compared to oral artemisinine (at the same dose) in 50 Plasmodium berghei infected mice. The study also included a non treated control group and a placebo suspension group. The drug was applied for 5 days, beginning at 4 hours after infection. All mice treated by subcutaneous application were alive and did not show any toxicity or side effects due artemisinine. There was no recrudescence during 60 days of follow-up. All mice in the control, placebo and oral artemisinin group died with hyperparasitemia. The result showed that subcutaneous formulation of artemisinin is more effective than oral ones at the same dose.

Study on the oral bio-availability of artemisinin solid dispersion system using Eudragit 100 as a carrier

The oral Bio-availability of two different capsule formulations of artmisinin was carried out in six rabbits divided in two groups and seven healthy male volunteers in a single-dose crossover design with randomization for dosing sequence. The experimental results showed that the relative bioavailability of the formulation, that was made of artemisinin solid dispersion system using Eudragit L100 as a carrier on ratio 1:1, was more two times higher than the modification of artemisinin capsules without any modifications. There was a good correlation between in vitro dissolution data obtained by dissolution test with the mean AUG values of each studied group after oral administration.

Therapeutic Efficacy of Naphthoquine Phosphate Combined with Artemisinine against Plasmodium knowlesi / 中国寄生虫学与寄生虫病杂志

Objective To study the antimalarial activity of naphthoquine phosphate combined with artemisinine against Plasmodium knowlesi in rhesus monkey.Methods Monkeys were randomly divided into 9 groups(3/group).The monkeys in groups A and B were treated i.g.once daily for 3 days with 6 or 10 mg/kg of naphthoquine phosphate respectively.Those in groups C and D were treated i.g.twice for the 1st day and once for the 2nd and 3rd day with 31.6 or 100 mg/kg of artemisinine respectively.In groups E, F and G, they were treated i.g.only once with the combination of naphthoquine phosphate 10 mg/kg and artemisinine 10, 20 or 25 mg/kg respectively.Groups H and I served as controls which were treated i.g.only once with 10 mg/kg of naphthoquine phosphate and 30 mg/kg of artemisinine respectively.Parasitemia was examined beginning 24 h after drug administration.The observation lasted 105 days when no more parasite was found.Results At 24 h after drug administration, the parasite reduction rate in all groups was higher than 90%.The parasite clearance time for groups E, F and G was(56.0?16.0),(53.3?4.6), and(56.0?8.0) h respectively, more rapid than that of Group H(69.3?4.6) h.There were 1, 3, 3, 2, 2, and 3 monkeys in groups A, B, D, E, F, and G respectively which were cured.No monkeys were cured in groups C, H and I.Conclusion The combination of naphthoquine phosphate and artemisinine is superior to the single component and the optimum proportion in the combination is 1:2.5 in treating P.knowlesi infection in monkeys.

Efficacy of Naphthoquine, Artemisinine and a Combination of the Two Drugs in the Treatment of Falciparum Malaria / 中国寄生虫学与寄生虫病杂志

Objective To compare the efficacy and safety of naphthoquine, artemisinine and a combination of the two drugs in the treatment of faciparum malaria. Methods Of 230 patients, 100 patients were treated with combined regime (Co-NQ), 100 patients were treated with naphthoquine (NQ) and 30 patients were treated with artemisinine (QHS). All patients were hospitalized for 7 days and followed up for 28 days. Results The mean fever clearance time for Co-NQ, NQ, and QHS was (17.5 ?12.3)h, (32.7?17.7)h and (18.1?9.7)h respectively; the mean parasite clearance time was (30.0?8. 8)h,(45.5?10.0)h and (29.1?6.0)h respectively; and the 28 days cure rate was 97.0% ,100.0% and 66.7% respectively. Conclusion The Co-NQ possesses benefits of both naphthoquine and artemisinine, acting rapidly, with a short course of only one dose and a high cure rate. The regime is well tolerated by patients.